The spectrum of SLC17A5-gene mutations resulting in free sialic acid-storage diseases indicates some genotype-phenotype correlation.
Lysosomal free sialic acid-storage diseases include the allelic disorders Salla disease (SD) and infantile sialic acid-storage disease (ISSD). The defective gene, SLC17A5, coding for the lysosomal free sialic acid transporter was recently isolated by positional cloning. In the present study, we have identified a large number of mutations in SLC17A5 in patients presenting with either Salla disease or the ISSD phenotype. We also report for the first time the exon-intron boundaries of SLC17A5. All Finnish patients with SD (n=80) had a missense mutation changing a highly conserved arginine to cysteine (R39C); 91% of them were homozygotes for this old founder mutation. The compound-heterozygote patients, with the founder mutation in only one allele, presented with a more severe phenotype than did the homozygote patients. The same R39C mutation was also found both in most of the Swedish patients with SD and in a heterozygous form in five patients from central Europe who presented with an unusually severe (intermediate) SD phenotype. Ten different mutations, including deletions, insertions, and missense and nonsense mutations, were identified in patients with the most severe ISSD phenotype, most of whom were compound heterozygotes. Our results indicate some genotype-phenotype correlation in free sialic acid-storage diseases, suggesting that the phenotype associated with the homozygote R39C mutation is milder than that associated with other mutations.
Aula
N
N
National Public Health Institute, Department of Human Molecular Genetics, Helsinki, Finland.
Salomäki
P
P
Timonen
R
R
Verheijen
F
F
Mancini
G
G
Månsson
J E
JE
Aula
P
P
Peltonen
L
L
D017668:Age of Onset; D000483:Alleles; D019943:Amino Acid Substitution / Q000235:genetics; D001483:Base Sequence; D004252:DNA Mutational Analysis; D005091:Exons / Q000235:genetics; D005387:Finland / Q000453:epidemiology; D018703:Founder Effect; D005787:Gene Frequency / Q000235:genetics; D005820:Genetic Testing; D006579:Heterozygote; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007438:Introns / Q000235:genetics; D016464:Lysosomal Storage Diseases / Q000453:epidemiology / Q000235:genetics* / Q000378:metabolism* / Q000503:physiopathology; D026901:Membrane Transport Proteins / Q000737:chemistry / Q000235:genetics*; D009154:Mutation / Q000235:genetics*; D019158:N-Acetylneuraminic Acid / Q000378:metabolism*; D027361:Organic Anion Transporters; D010641:Phenotype; D016133:Polymerase Chain Reaction; D011487:Protein Conformation; D012333:RNA, Messenger / Q000032:analysis / Q000235:genetics; D013548:Sweden / Q000453:epidemiology; D027981:Symporters
D026901:Membrane Transport Proteins; D027361:Organic Anion Transporters; D012333:RNA, Messenger; D027981:Symporters; C421224:sialic acid transport proteins; D019158:N-Acetylneuraminic Acid